Edelweiss: Cancer Open Access (ISSN: 2689-6737)
Editor


Director
Flow Cytometry-Research & Regenerative Medicine
IASO Hospital
Athens, Greece
Biography
Vasiliki is Director at Flow Cytometry-Research and Regenerative Medicine Department, IASO Hospital in Athens, Greece.
Research Interest
Her work purpose is to find new helpful application in regenerative medicine, evaluate the risk factors for infusion and try to make clear and easy to access measurements by flow cytometry. My work quantifies and ranks all risk of flow cytometry enumeration to prevent and minimize the false positive results from different cytometer uses, make easier and accessible QC schemes for lab use and also working to establish combinations of monoclonal antibodies for mesenchymal and adipose tissue stem cell enumeration for applications in regenerative medicine.
Keywords
- Cancer stem cells
- Breast cancer
- Lung cancer
- Thyroid cancer
- Skin cancers
- Pancreatic cancer
- Heart cancer
- Ovarian cancer
- Paediatric radiology
- Salivary gland tumours
- Bladder cancer
- Urethral cancer
- Prostate cancer
- Myelodysplastic syndromes
- Myeloproliferative neoplasms
- Oncology
- Leukemia
- Stomach cancer
- Esophageal cancer
- Colorectal cancer
- Cancer prevention
- Head and neck cancer
- Carcinogenesis
- Chemotherapy
- Radiation therapy
- Lymph node
- Cancer screening
- Nasopharynx cancer
- Transcatheter arterial chemoembolization
- Cancer biomarker
- Monoclonal antibody therapy
- Hepatocellular carcinoma
- cancer vaccine
- Germ-cell tumor
- Cancer immunotherapy
- Cellular immunotherapy
- Antibody therapy
- Cytokine therapy
- Trophoblast glycoprotein
- Coleys toxins
- Combinatorial ablation
- Cryoimmunotherapy
- Photoimmunotherapy
- Treatment of cancer
- Brain metastases
- Oncofertility
- Oncovirus
- Cancer biology
- Radiation oncology
- Gallbladder cancer
- Oncogenesis
- Cancer epigenetics
- RNA silencing treatment
- sialolipoma
- Odontogenic keratocyst
- Probiotics cancer treatment
- Oncofertility Treatment
- Bone marrow failure disorder
- View more
